PARIS — The survival benefits of primary-prevention device therapy seen in seminal trials reported in the early 2000s still apply today, suggests a registry study from Sweden that also saw gross ...
New report in the Canadian Journal of Cardiology shows that rural patients have lower referral rates and higher refusal rates for implantable cardioverter defibrillators, a standard device therapy for ...
Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...
PROFID EHRA, the first clinical trial seeking to challenge routine implantation of defibrillators in heart attack survivors with heart failure has just been launched. The European Society of ...
Medtronic's EV ICD System Proves Effective in Cardiac Arrhythmia Management: Long-term Study Results
Medtronic plc (NYSE:MDT) announced longer-term follow-up results of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) System, designed to treat dangerously fast heart ...
Patients with heart failure (HF) and left ventricular (LV) dysfunction have been shown to derive clinical benefit from cardiac resynchronization therapy (CRT) and from implantable ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
The current iteration of the ICD is the ICD-11. It was accepted by the World Health Assembly in May 2019 and officially came into use in January 2022. Non-member countries adopt new versions of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results